Glycerin/lidocaine/petrolatum/phenylephrine topical Interactions
There are 124 drugs known to interact with glycerin/lidocaine/petrolatum/phenylephrine topical, along with 8 disease interactions. Of the total drug interactions, 8 are major, 109 are moderate, and 7 are minor.
Medications known to interact with glycerin/lidocaine/petrolatum/phenylephrine topical
Note: Showing generic names only.
- acebutolol
- acetaminophen
- albuterol
- aminosalicylic acid
- amiodarone
- amyl nitrite
- arformoterol
- atenolol
- atovaquone
- dapsone
- dapsone topical
- desvenlafaxine
- dihydroergotamine
- divalproex sodium
- dofetilide
- dronedarone
- droxidopa
- duloxetine
- ibutilide
- ifosfamide
- indacaterol
- iobenguane I 131
- isocarboxazid
- isoetharine
- isoniazid
- isoproterenol
- isosorbide
- isosorbide dinitrate
- isosorbide mononitrate
- mafenide topical
- mepivacaine
- metaproterenol
- methylene blue
- methylergonovine
- methysergide maleate
- metoclopramide
- metoprolol
- mexiletine
- midodrine
- milnacipran
- penbutolol
- phenazopyridine
- phenelzine
- phenobarbital
- phenytoin
- pindolol
- pirbuterol
- prilocaine
- primaquine
- procaine
- procaine penicillin
- procarbazine
- propranolol
- safinamide
- salmeterol
- selegiline
- sibutramine
- silver nitrate topical
- silver sulfadiazine topical
- sodium nitrite
- solriamfetol
- sotalol
- sulfadiazine
- sulfamethizole
- sulfamethoxazole
- sulfasalazine
- sulfisoxazole
- tafenoquine
- tapentadol
- terbutaline
- tetracaine
- timolol
- tocainide
- tranylcypromine
- trazodone
- trimethoprim
Glycerin/lidocaine/petrolatum/phenylephrine topical disease interactions
There are 8 disease interactions with glycerin / lidocaine / petrolatum / phenylephrine topical which include:
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- cardiovascular
- BPH
- diabetes
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.